Content
FDA approved for more than 25 years
Let’s talk 5mg finasteride vs 1mg—two different doses, one powerful hair loss treatment.
Finasteride is the active ingredient in Propecia®, an oral medication that’s clinically-proven to treat and prevent male pattern baldness. It was approved by the Food and Drug Administration (FDA) back in 1992 to treat benign prostatic hyperplasia, and in 1997, it was also approved to fight hair loss..
Finasteride ) is one of two medications (minoxidil (Rogaine®) is the other) proven to help men maintain their hair. Using finasteride may also help you regrow hair.
So what’s the difference between finasteride 1mg and finasteride 5mg and which dose is right for you? . Read on to find out how they work, when to use them, and which dose makes the most sense for you.
Content
Before we get into the nitty gritty of how these two common finasteride doses compare, here’s a quick look at what makes them unique.
1mg finasteride | 5mg finasteride | |
---|---|---|
Available from hims | Yes | No |
How it works | Hair loss in men, male pattern baldness (androgenetic alopecia) | Enlarged prostate |
Effectiveness | Impairs 5-alpha reductase activity to reduce DHT levels, stop male pattern baldness, and encourage hair regrowth | Causes prostate shrinkage to improve the flow of urine |
Common side effects | Helpful for most men looking to maintain and regrow hair (especially when paired with minoxidil) | Helpful for most men experiencing urinary symptoms due to enlarged prostate |
When to expect results | Minimal risk of sexual side effects | Greater chance of sexual side effects |
Finasteride is in a class of medications called 5-alpha reductase inhibitors, or 5α-reductase inhibitors. They work by inhibiting the effects of an enzyme known as 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for male pattern hair loss.
5-alpha reductase blockers reduce DHT levels, slowing down, stopping, or reversing the effects of male pattern baldness. They can also encourage hair regrowth and increase hair count.
Research shows that a typical dose of finasteride reduces DHT levels in your blood by as much as 70 percent compared with a placebo.
It can also reduce DHT levels by 90 percent in your prostate gland, which can effectively treat androgenic alopecia and an enlarged prostate.
The typical finasteride dosage for hair loss is 1mg per day, but your healthcare provider will decide what’s best for you. Most hair loss treatments containing finasteride use this dose, including the original 1mg Propecia tablets.
Research backs this up. In one study, 80 percent of men saw improvements after using 1mg finasteride for 12 months to treat male pattern hair loss.
Another older study found that 83 percent of men maintained their hair after two years on 1mg finasteride compared to just 28% on a placebo.
But here's the thing: More finasteride isn’t necessarily better. For hair loss, 1mg of finasteride per day is enough. Taking more won’t improve results and could increase your risk of side effects.
When should men consider a higher dose of finasteride? While the 1mg dose of finasteride is effective for hair loss treatment, the 5mg dose targets prostate-related issues.
Typically, the 5mg dose of finasteride is prescribed for benign prostatic hyperplasia (BPH), or enlarged prostate.
BPH is a non-cancerous condition that can make urination difficult due to prostate enlargement pressing against the urethra. Nearly all men will eventually experience BPH at some point in their lives.
The 5mg finasteride dose for BPH, often sold under the brand name Proscar®, helps control prostate growth and ease BPH symptoms, like trouble urinating.
Remember, thisdosage of finasteride is not for hair loss.
Finasteride is generally safe and doesn’t interact with other drugs. However, like all prescription medications, it can have potential side effects.
Fortunately, less than two percent of men report these issues, suggesting a low overall risk.
Possible adverse events include:
Skin rashes
Fatigue
Dizziness
Headaches
Swelling in the lips and face
Breast swelling or nipple discharge
The most common side effects are sexual health-related, like decreased libido, erectile dysfunction (ED), and ejaculation disorder.
Here’s how these possible sexual side effects vary based on dosage:
Potential side effects of finasteride at a 1mg dose include:
Decreased sex drive
Erectile dysfunction (ED)
Serious side effects from finasteride treatment are highly uncommon, especially with the smaller dose. And decreased libido — the most common side effect of finasteride — only affects 1.8 percent of men who take it.
Compared to the 1mg dose, finasteride 5mg has a few more noticeable side effects.
In clinical trials, eight percent of men on finasteride 5mg experienced ED, six percent of men reported reduced interest in sex, and just under four percent noticed decreased ejaculation volume.
Other side effects reported by men using finasteride 5mg include:
Rash
Breast tissue enlargement
Breast tissue tenderness
While discontinuation of both lower and higher doses of finasteride due to sexual dysfunction is rare, it does happen. Finasteride and Prostate Cancer Risks
Finasteride has been shown to lower the overall risk of prostate cancer. However, some old research from 1993 suggested it might increase the risk of high-grade prostate cancer.
These earlier findings are now believed to due to detection bias and other factors. Today, the scientific consensus is that finasteride is safe hair loss treatment for most men.
A 2019, study involving 10,000 participants found no link between finasteride and an elevated risk of prostate cancer.
For more details on finasteride’s side effects and guidance on what to do if you experience any, check out our full guide to the side effects of finasteride.
For men pursuing hair restoration, finasteride is usually taken as a pill, but it can also be applied directly to the hair and scalp.
Topical finasteride isn’t yet FDA-approved yet, scientists are working on it. Recent clinical studies show that topical finasteride is just as effective as oral finasteride, but might be safer.
Though it can cause skin irritation like many topical treatments, topical finasteride has less of an impact on your body overall.
Trials reveal that the concentration in your bloodstream is over 100 times lower with topical finasteride vs. the oral version.
Because it’s not cycling through your entire system, it affects fewer organs and tissues.
Finasteride comes in 1mg or 5mg tablets. For male pattern baldness, stick to the 1mg dose daily, or follow a healthcare professional’s advice.
Here’s a recap of what to know about 5mg finasteride vs 1 mg:
It’s effective. Finasteride works. Just 1 mg of finasteride is proven to effectively treat male pattern baldness. You’ll typically see results within 3-6 months, and with consistent use, most men retain the majority of their hair even two years later.
Combined treatment might be more powerful. Finasteride is even more effective for male hair loss when combined with minoxidil. Curious about this option? Talk to a healthcare professional.
More isn’t better. When taking finasteride for hair loss, a higher dosage won’t reduce the severity of your hair loss, improve hair growth, or speed up your results. But it may increase your risk of sexual side effects, so we strongly recommend saving the 5mg dose for BPH needs.
If your goal is ditching hair loss for good, check out our wide range of proven hair loss treatments for men, including FDA-approved medications like finasteride and minoxidil.
Try our Saw Palmetto shampoo, formulated to help thicken hair, our combination minoxidil and finasteride spray, or our Hair Power Pack — which includes several of our best hair loss treatment products for men.
When you’re ready to connect with a licensed healthcare provider, take our free online quiz to get started.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
Dr. Knox Beasley is a board certified dermatologist specializing in hair loss. He completed his undergraduate studies at the United States Military Academy at West Point, NY, and subsequently attended medical school at Tulane University School of Medicine in New Orleans, LA.
Dr. Beasley first began doing telemedicine during his dermatology residency in 2013 with the military, helping to diagnose dermatologic conditions in soldiers all over the world.
Dr. Beasley is board certified by the American Board of Dermatology, and is a Fellow of the American Academy of Dermatology.
Originally from Nashville, TN, Dr. Beasley currently lives in North Carolina and enjoys spending time outdoors (with sunscreen of course) with his wife and two children in his spare time.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977. https://onlinelibrary.wiley.com/doi/10.1111/cup.13027
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867906/
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147. https://onlinelibrary.wiley.com/doi/10.1111/cup.12569
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j. https://pubmed.ncbi.nlm.nih.gov/26990472/
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb. https://pubmed.ncbi.nlm.nih.gov/26437285/
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115. https://pubmed.ncbi.nlm.nih.gov/25750965/
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143. https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs13671-013-0043-0
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26. https://www.urotoday.com/volume-5-2012/vol-5-issue-3/51132-a-retrospective-study-evaluating-the-efficacy-and-tolerability-of-intra-abdominal-once-yearly-histrelin-acetate-subcutaneous-implants-in-patients-with-advanced-prostate-cancer.html
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html